Incannex Healthcare (ASX: IHL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Incannex Healthcare Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Incannex Healthcare (ASX: IHL)
Latest News
Cannabis Shares
How have ASX cannabis shares been performing so far in 2022?
Mergers & Acquisitions
Incannex (ASX:IHL) share price slips on acquisition news
Healthcare Shares
Here's why the Incannex (ASX:IHL) share price is on ice today
Share Gainers
The Incannex (ASX:IHX) share price is up a whopping 50% in a week. What's the deal?
Healthcare Shares
What's going on with the Incannex (ASX:IHL) share price today?
Share Gainers
These were the best-performing ASX cannabis shares in 2021
Share Gainers
Here's why the Incannex (ASX:IHL) share price spiked 12% today
Cannabis Shares
What's the outlook for ASX Cannabis shares in 2022?
Cannabis Shares
What's dragging the Incannex (ASX:IHL) share price 5% lower today?
Cannabis Shares
These were the top performing ASX cannabis shares in November
Healthcare Shares
These were the 5 best performing ASX healthcare shares in November
52-Week Highs
Here's why the Incannex (ASX:IHL) share price has rocketed 60% in a month
Frequently Asked Questions
-
Incannex listed on the ASX in May 2007.
-
No, Incannex has not yet paid out any dividends.
IHL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Incannex Healthcare
Incannex Healthcare Ltd (ASX: IHL) is a developer of cannabinoid and psychedelic compound medicines. It is currently involved in clinical programs for the treatment of six conditions: Obstructive Sleep Apnea (OSA), Generalised Anxiety Disorder (GAD), traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions.
The company has an Australian license to import, export, and distribute medicinal cannabis products and has a line of cannabinoid products.